Table 4.
A | ||
---|---|---|
Combined cohort | ||
Total urine output over 2 hours | Sensitivity | Specificity |
≤100 ml | 90.2% | 60.0% |
<200 ml | 87.1% | 84.1% |
<300 ml | 85.3% | 88.0% |
<400 ml | 66.7% | 88.0% |
<500 ml | 50.5% | 88.0% |
B Sensitivity and specificity of two hour urine thresholds for progression to AKIN III or death | ||
Combined cohort | ||
Total urine output over two hours | Sensitivity | Specificity |
<100 ml | 93.3% | 53.2% |
<200 ml | 90% | 74.2% |
<300 ml | 87.8% | 77.4% |
<400 ml | 66.7% | 77.4% |
<500 ml | 53.3% | 77.4% |
The primary outcome was Acute Kidney Injury Network (AKIN) stage III within 14 days of the furosemide stress test.
The primary outcome was Acute Kidney Injury Network (AKIN) stage III or death within 14 days of the furosemide stress test.